Singapore General Hospital

Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging

Retrieved on: 
Thursday, November 30, 2023
Ministry, Health, CGH, Hospital, Bed, MOH, Patient, Medical imaging, Algorithm, SGH, National health insurance, Therapy, Singapore General Hospital, INSIGHT, Diagnosis, NTT DATA, SingHealth, Health care, Changi General Hospital, AI, NTT, Ministry of Health, Medical device, Nursing, Innovation

As part of the agreement, Lunit collaborated with CARPL to provide NTT DATA with Lunit INSIGHT CXR.

Key Points: 
  • As part of the agreement, Lunit collaborated with CARPL to provide NTT DATA with Lunit INSIGHT CXR.
  • AimSG allows public healthcare institutions to integrate AI imaging solutions, like Lunit INSIGHT CXR, seamlessly into their existing clinical radiology workflow, enhancing medical professionals' diagnostic capabilities and efficiency.
  • Healthcare institutions that have adopted Lunit's AI solution through AimSG have had a positive response and are looking forward to improving the medical imaging workflow.
  • "The AimSG platform enables clinicians from public healthcare institutions to deploy AI algorithms to help them deliver better healthcare to the population.

AWAK Technologies Announces FDA Breakthrough Device Designation for their Artificial Intelligence Enabled Kidney Disease Prediction Tool

Retrieved on: 
Monday, November 27, 2023
Chronic kidney disease, Renal replacement therapy, KDPP, Food, Kidney disease, Risk, Artificial intelligence, Kansai Medical University Hospital, Patient, Medtech, Dialysis, SGH, FDA, CKD, Breakthrough, Machine learning, Caregiver, Singapore General Hospital, AWAK, Diagnosis, Partnership, Health, Ever Fortune, Pharmaceutical industry, Medical device

SINGAPORE, Nov. 27, 2023 /PRNewswire/ -- AWAK Technologies (AWAK), a pioneering medical technology company developing a wearable dialysis product and other complementary solutions for chronic kidney disease (CKD) management, today announced that its kidney disease progression prediction (KDPP) Artificial Intelligence (AI) model for CKD patient care has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA).

Key Points: 
  • SINGAPORE, Nov. 27, 2023 /PRNewswire/ -- AWAK Technologies (AWAK), a pioneering medical technology company developing a wearable dialysis product and other complementary solutions for chronic kidney disease (CKD) management, today announced that its kidney disease progression prediction (KDPP) Artificial Intelligence (AI) model for CKD patient care has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA).
  • The two companies entered in a strategic partnership in September 2021 to revolutionize the diagnosis, treatment, and management of kidney disease by building solutions using medical big data and artificial intelligence.
  • The Breakthrough Device designation from the FDA is granted to novel products that demonstrate the potential to offer substantial benefits over existing medical devices or technologies.
  • Abel Ang, Chairman of AWAK Technologies, said: "We are thrilled to have received a second Breakthrough Device Designation from the US FDA, making us one of the few Asia-based MedTech companies with multiple FDA breakthrough device designations.

Healthcare Information Systems Industry Expected to Grow at CAGR of 13.3% from 2023 to 2030 - Grand View Research, Inc.

Retrieved on: 
Wednesday, July 12, 2023
Informatics, IHI, Telehealth, SingHealth, Hospital, CMS, Information, Office of Inspector General, U.S. Department of Health and Human Services, HHS, DME, Health, Big data, Pharmacy, Workflow, Patient satisfaction, RFID, Sunrise, COVID-19, RCM, Kaiser Family Foundation, Intelligence, Medicine, Automation, USD, Pan American Health Organization, Integrated Health Information Systems, HIS, Government, Singapore General Hospital, Investment, EHR, Patient safety, Laboratory, SAN, AI, R, Kids Count Data Book, Pharmaceutical industry

SAN FRANCISCO, July 12, 2023 /PRNewswire/ -- The global healthcare information systems industry size reached USD 406.4 billion in 2022 and will exhibit a CAGR of 13.3% from 2023 to 2030, according to the " Healthcare Information Systems Industry Data Book, 2023 - 2030 ," published by Grand View Research.

Key Points: 
  • SAN FRANCISCO, July 12, 2023 /PRNewswire/ -- The global healthcare information systems industry size reached USD 406.4 billion in 2022 and will exhibit a CAGR of 13.3% from 2023 to 2030, according to the " Healthcare Information Systems Industry Data Book, 2023 - 2030 ," published by Grand View Research.
  • Pan American Health Organization notes that around 30,000 paper-based files will be converted to electronic medical records—largely attributed to health information systems (HIS).
  • An uptick in implementing digital health, electronic health record (EHR) and durable medical equipment (DME) have accentuated the demand for hospital information systems.
  • The global hospital information system market size garnered USD 118.2 billion in 2022 and could witness a robust CAGR of 17.7% through 2030.

Healthcare Information Systems Industry Expected to Grow at CAGR of 13.3% from 2023 to 2030 - Grand View Research, Inc.

Retrieved on: 
Wednesday, July 12, 2023
Informatics, IHI, Telehealth, SingHealth, Hospital, CMS, Information, Office of Inspector General, U.S. Department of Health and Human Services, HHS, DME, Health, Big data, Pharmacy, Workflow, Patient satisfaction, RFID, Sunrise, COVID-19, RCM, Kaiser Family Foundation, Intelligence, Medicine, Automation, USD, Pan American Health Organization, Integrated Health Information Systems, HIS, Government, Singapore General Hospital, Investment, EHR, Patient safety, Laboratory, SAN, AI, R, Kids Count Data Book, Pharmaceutical industry

SAN FRANCISCO, July 12, 2023 /PRNewswire/ -- The global healthcare information systems industry size reached USD 406.4 billion in 2022 and will exhibit a CAGR of 13.3% from 2023 to 2030, according to the " Healthcare Information Systems Industry Data Book, 2023 - 2030 ," published by Grand View Research.

Key Points: 
  • SAN FRANCISCO, July 12, 2023 /PRNewswire/ -- The global healthcare information systems industry size reached USD 406.4 billion in 2022 and will exhibit a CAGR of 13.3% from 2023 to 2030, according to the " Healthcare Information Systems Industry Data Book, 2023 - 2030 ," published by Grand View Research.
  • Pan American Health Organization notes that around 30,000 paper-based files will be converted to electronic medical records—largely attributed to health information systems (HIS).
  • An uptick in implementing digital health, electronic health record (EHR) and durable medical equipment (DME) have accentuated the demand for hospital information systems.
  • The global hospital information system market size garnered USD 118.2 billion in 2022 and could witness a robust CAGR of 17.7% through 2030.

Zeta Surgical Announces Successful Treatment of First Patient in Neurosurgical Navigation Clinical Trial at Singapore's National Neuroscience Institute

Retrieved on: 
Thursday, June 22, 2023
NNI, Tan Tock Seng Hospital, Deafness in the Democratic Republic of the Congo, Clinical trial, Medicine, SingHealth, Harvard Medical School, Neuroscience, Singapore General Hospital, Hospital, Neurosurgery, Patient, Entrepreneurship, Safety, Medical device, Newsweek

SINGAPORE, June 22, 2023 /PRNewswire/ -- Zeta Surgical, a surgical robotics and mixed reality company, has successfully treated its first patient using the Zeta Cranial Navigation System as part of their first-in-human trial at Singapore's National Neuroscience Institute (NNI).

Key Points: 
  • SINGAPORE, June 22, 2023 /PRNewswire/ -- Zeta Surgical, a surgical robotics and mixed reality company, has successfully treated its first patient using the Zeta Cranial Navigation System as part of their first-in-human trial at Singapore's National Neuroscience Institute (NNI).
  • The trial is led by NNI Associate Consultant Dr. Min Wei Chen and conducted at Singapore General Hospital and Tan Tock Seng Hospital.
  • "This trial marks our first step towards making surgical guidance truly accessible across neurosurgery and neuroscience," says Raahil Sha, Co-Founder and Chief Technology Officer of Zeta Surgical.
  • "We are thrilled to be partnering with NNI in our mission to make surgeries more precise, safe, and effective."

Medtronic to present new data on its intelligent dosing platforms at the American Diabetes Association 83rd Scientific Sessions

Retrieved on: 
Monday, June 12, 2023
CGM, University Children's Hospital Basel, MBA, Doctor of Philosophy, A1C, Metabolism, MD, Patient, Medtronic, Ageing, R, Randomized controlled trial, American Diabetes Association, ADA, NYSE, Diabetes, Research, SR, Glucose meter, Spinal cord stimulator, Hospital, FDA, Adaptive Deep Brain Stimulation, Insulin, Endocrinology, FOH, MDI, T1D, PDT, Cincinnati Children's Hospital Medical Center, Singapore General Hospital, Children's Hospital & Medical Center, MPH, Real Life, Trial of the century, System Settings, ADAPT, SIP, Poster, Pharmaceutical industry, Birth control, Health insurance, Nursing, Management, Brain, Carbohydrate

DUBLIN, June 12, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in medical technology, today announced its participation in the upcoming American Diabetes Association's (ADA) 83rd Scientific Sessions in San Diego on Jun.

Key Points: 
  • DUBLIN, June 12, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in medical technology, today announced its participation in the upcoming American Diabetes Association's (ADA) 83rd Scientific Sessions in San Diego on Jun.
  • The following poster and oral scientific data presentations represent the work of Medtronic employees and independent investigators using Medtronic devices in their research.
  • Poster presentations will be available to all attendees for viewing throughout the conference.
  • 26 at 11:30 a.m. PDT
    "Real-World Clinical Data on the Extended Infusion Set" – poster presentation (910-P) by Tim Kwa, senior product engineer, Medtronic on Sunday, Jun.

The Adoption Of Digital Imaging And Video Streaming Technology Is On The Rise In The Digital Pathology Market: The Business Research Company

Retrieved on: 
Wednesday, October 19, 2022
Sectra AB, Growth, Pathology, Danaher, Workflow, CAGR, Telepathology, Philips, Research, Singapore, Medical laboratory, Danaher Corporation, R, Marketing, SGH, Health, Prognosis, Leica Biosystems, Singapore General Hospital, Artificial intelligence, COVID-19, Solution, Patient, Medical imaging

LONDON, Oct. 19, 2022 /PRNewswire/ -- Companies in the digital pathology market are adopting digital imaging and video streaming technology which allows the sharing of real-time images to any location worldwide. The telepathology makes it easier for doctors to work together to make quick diagnoses. Patients experience suffering while waiting for test findings, which could affect their prognosis. For instance, in June 2020, the Mayo Clinic Department of Laboratory Medicine and Pathology initiated an enterprise-wide digital pathology implementation of the Sectra digital slide review and image storage and management system to enable digital pathology.

Key Points: 
  • LONDON, Oct. 19, 2022 /PRNewswire/ -- Companies in the digital pathology market are adopting digital imaging and video streaming technology which allows the sharing of real-time images to any location worldwide.
  • For instance, in June 2020, the Mayo Clinic Department of Laboratory Medicine and Pathology initiated an enterprise-wide digital pathology implementation of the Sectra digital slide review and image storage and management system to enable digital pathology.
  • As per the digital pathology market research, research and development (R&D) activities for the development of new diagnostic solutions is amongst the important digital pathology market trends .
  • Danaher Corporation was the largest competitor in the digital pathology market in 2021, with an 18.45% share of the market.

The Adoption Of Digital Imaging And Video Streaming Technology Is On The Rise In The Digital Pathology Market: The Business Research Company

Retrieved on: 
Wednesday, October 19, 2022
Sectra AB, Growth, Pathology, Danaher, Workflow, CAGR, Telepathology, Philips, Research, Singapore, Medical laboratory, Danaher Corporation, R, Marketing, SGH, Health, Prognosis, Leica Biosystems, Singapore General Hospital, Artificial intelligence, COVID-19, Solution, Patient, Medical imaging

LONDON, Oct. 19, 2022 /PRNewswire/ -- Companies in the digital pathology market are adopting digital imaging and video streaming technology which allows the sharing of real-time images to any location worldwide. The telepathology makes it easier for doctors to work together to make quick diagnoses. Patients experience suffering while waiting for test findings, which could affect their prognosis. For instance, in June 2020, the Mayo Clinic Department of Laboratory Medicine and Pathology initiated an enterprise-wide digital pathology implementation of the Sectra digital slide review and image storage and management system to enable digital pathology.

Key Points: 
  • LONDON, Oct. 19, 2022 /PRNewswire/ -- Companies in the digital pathology market are adopting digital imaging and video streaming technology which allows the sharing of real-time images to any location worldwide.
  • For instance, in June 2020, the Mayo Clinic Department of Laboratory Medicine and Pathology initiated an enterprise-wide digital pathology implementation of the Sectra digital slide review and image storage and management system to enable digital pathology.
  • As per the digital pathology market research, research and development (R&D) activities for the development of new diagnostic solutions is amongst the important digital pathology market trends .
  • Danaher Corporation was the largest competitor in the digital pathology market in 2021, with an 18.45% share of the market.

HMA conference to look at future of Hospital at Home model in Asia

Retrieved on: 
Wednesday, September 28, 2022
Traction, Epworth HealthCare, Department, Department of Medicine – University of Pamplona, Health, Philips, NUHS, Hospital, Founder CEO, Ministry, Well-being, Ministry of Health (Singapore), Lafayette Home Hospital, Division, Dr. Jeyasekharan Hospital & Nursing Home, Senior, Singapore General Hospital, Heart failure, Hah, Patient, Medical home, CEO, Program director, Solution, Technology, Consultant, Caregiver, Mobile, MIC, MOH, FMCC, Health insurance, Medical device

This is why Hospital Management Asia is organising the Hospital@Home Asia conference, with Singapore's MOH Office for Healthcare Transformation as knowledge partner.

Key Points: 
  • This is why Hospital Management Asia is organising the Hospital@Home Asia conference, with Singapore's MOH Office for Healthcare Transformation as knowledge partner.
  • The one-day event on 25 November will delve into different aspects of hospital at home programmes with a particular focus on Singapore's MIC@Home (Mobile Inpatient Care at Home).
  • Prof Dan and Dr Montalto will be joining the first panel discussion looking at whether Hospital at Home is the future of acute medicine.
  • Registration is now open - click on this link for more information on the agenda, speakers, and to register: www.hospitalmanagementasia.com/events/hospital-at-home/.

Dentures Global Market Report 2022: Prevalence of Periodontal and Edentulism Diseases to Propel Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 20, 2022
Dental, Health, American Academy, Singapore General Hospital, Inflammation, Dentures, Center, Organization, 3D, Dental, Prevalence, Gingivitis, Tooth, American Academy of Periodontology, Designer, World Health Organization, Acquisition, Growth, Periodontal disease, Patient, Solution, Korea Disease Control and Prevention Agency, WHO, Degenerative disease, Ageing, DSO, Rural Health Workforce and The Patient Protection and Affordable Care Act, Computer-aided design, Disease, Dentistry, 3D printing

The "Dentures Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Dentures Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The regions covered in the dentures market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
  • The rise in the prevalence of periodontal and edentulism diseases is expected to propel the growth of the dentures market going forward.
  • Thus, the high prevalence of periodontal diseases will drive the dentures market growth.